Recall: SCA Pharmaceuticals Furosemide 100 Mg In 0.9% Sodium Chloride
On 2018-09-06, the FDA announced that SCA Pharmaceuticals is conducting a recall on Furosemide 100 Mg In 0.9% Sodium Chloride due to a possible presence of precipitate. The recalled products were sold under the brand name(s) SCA Pharmaceuticals during an unspecified time period throughout the regions shown in the map below.
In recent months, there have been 1 drugs recalls due to potential presence of precipitate. Additionally, there have been 29 drug and medical device recalls due to other health hazards as well as 71 food recalls.
Company Contact Information:
Name: SCA Pharmaceuticals
Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.
Detailed Recall Information
Regions Where Sold: Connecticut, Virginia and Washington
Product Description: Furosemide 100 mg in 0.9% Sodium Chloride
Brand Name(s): SCA Pharmaceuticals
Reason for Recall: Presence of Precipitate
Official Recall Date: 2018-09-06
Additional information provided by the FDA.gov:
SCA Pharmaceuticals LLC ("SCA Pharma") is voluntarily recalling 7 lots of the injectable product Furosemide 100 mg in 0.9% Sodium Chloride 100 mg bag to the consumer level. This product is being recalled for visible particulate matter believed to be furosemide precipitate. Read More.
More information may be available at FDA.gov
Latest Safety Recalls
Select image for details, including additional styles.
Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.